Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Stereotaxis, Inc.

Market Cap 178M 153M 141M 133M 249M 16.82B 251M 1.67B 650M 8.24B 668M 653M 28.54B P/E Ratio 2026 *
-9.1x
P/E Ratio 2027 * -12.1x
Enterprise Value 178M 153M 141M 133M 249M 16.82B 251M 1.67B 650M 8.24B 668M 653M 28.54B EV / Sales 2026 *
4.51x
EV / Sales 2027 * 3.34x
Free-Float
84.63%
Yield 2026 *
-
Yield 2027 * -
1 day-1.09%
1 week-1.62%
Current month-8.08%
1 month-1.62%
3 months-4.71%
6 months-23.53%
Current year-20.87%
1 week 1.78
Extreme 1.78
1.92
1 month 1.7
Extreme 1.7
2.1
Current year 1.7
Extreme 1.7
2.86
1 year 1.7
Extreme 1.7
3.59
3 years 1.33
Extreme 1.33
3.59
5 years 1.33
Extreme 1.33
10.3
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer 39 2017-02-02
Director of Finance/CFO 57 2019-09-30
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 2005-01-31
Chairman 39 2017-02-02
Director/Board Member 71 2016-09-28
Date Insider Type Main position Quantity % Market Cap.
04-10Free

Chief Financial Officer

40,000 0.0411%
01-01Free

Director

46,948 0.0503%
01-01Free

Director

46,948 0.0503%
Change 5-day change 1-year change 3-year change Capi.($)
-1.09%-1.62%-16.13%+13.04% 178M
-0.23%-4.34%+16.68%-12.04% 176B
+0.12%-2.24%-19.65%+26.63% 148B
+0.14%-3.75%-9.83%-25.00% 128B
+0.34%-4.17%-53.77%-13.62% 69.74B
+2.67%+1.19%+18.39%-3.65% 51B
+0.97%+0.60%-23.33%-33.14% 45.7B
-1.72%-5.27%+7.83%+5.95% 36.25B
+0.78%-2.86%+3.66%+33.93% 35.4B
-2.36%-4.21%-13.22%-19.61% 28.76B
Average -0.04%-1.80%-8.94%-2.75% 71.87B
Weighted average by Cap. +0.13%-2.86%-7.07%-4.43%

Financials

2026 *2027 *
Net sales 39.4M 33.95M 31.27M 29.36M 55.12M 3.73B 55.7M 369M 144M 1.82B 148M 145M 6.32B 53.28M 45.91M 42.28M 39.7M 74.53M 5.04B 75.31M 500M 195M 2.47B 200M 196M 8.55B
Net income -19.4M -16.72M -15.4M -14.45M -27.14M -1.83B -27.43M -182M -70.87M -898M -72.81M -71.26M -3.11B -13.62M -11.74M -10.81M -10.15M -19.06M -1.29B -19.26M -128M -49.77M -631M -51.13M -50.05M -2.19B
Net Debt - -
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Employees
131
Date Price Change Volume
26-06-16 1.820 $ -1.09% 348,445
26-06-15 1.840 $ 0.00% 262,291
26-06-12 1.840 $ +1.10% 204,946
26-06-11 1.820 $ +0.55% 201,475
26-06-10 1.810 $ -2.16% 305,203
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.820USD
Average target price
4.125USD
Spread / Average Target
+126.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STXS Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!